electroCore, Inc. (ECOR) Operating Margin
- Operating margin · 12 months: Value -37.64%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -37.64% | Operating income / revenue. Period ending 2026-06-30. $-13.91M ÷ $36.97M × 100 ≈ -37.64% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -13.91M USD | Operating Income (Loss) |
| Revenue | 36.97M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 4.79M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 42.95M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-13.91M | $36.97M | $4.79M | (m) | $42.95M | -37.64% |
| 2026-03-31 | $-14.65M | $34.90M | $4.45M | (m) | $42.26M | -41.97% |
| 2025-12-31 | $-13.15M | $32.03M | $4.24M | (m) | $38.21M | -41.06% |
| 2025-09-30 | $-13.28M | $29.84M | $4.17M | $2.62M | $36.33M | -44.52% |
| 2025-06-30 | $-13.05M | $27.70M | $4.01M | $2.48M | $34.26M | -47.11% |
| 2025-03-31 | $-12.13M | $26.46M | $3.91M | $2.60M | $32.08M | -45.87% |
| 2024-12-31 | $-12.16M | $25.18M | $3.79M | $2.36M | $31.20M | -48.30% |
| 2024-09-30 | $-13.05M | (m) | $3.89M | $2.66M | $29.82M | (m) |
| 2024-06-30 | $-14.52M | $21.28M | $3.49M | $3.39M | $28.93M | -68.25% |
| 2024-03-31 | $-16.92M | $18.69M | $3.23M | $3.91M | $28.47M | -90.52% |
| 2023-12-31 | $-19.27M | (m) | $2.80M | $5.32M | $27.17M | (m) |
| 2023-09-30 | $-21.23M | $13.40M | $2.34M | $5.84M | $26.44M | -158.43% |
| 2023-06-30 | $-22.66M | $10.87M | $1.94M | $6.21M | $25.38M | -208.50% |
| 2023-03-31 | $-23.49M | $9.47M | $1.71M | $6.39M | $24.85M | -247.97% |
| 2022-12-31 | $-22.87M | $8.59M | $1.62M | $5.52M | $24.33M | -266.22% |
| 2022-09-30 | $-22.43M | $7.52M | $1.27M | $4.63M | $24.05M | -298.13% |
| 2022-06-30 | $-20.86M | $7.03M | $1.37M | $3.49M | $23.04M | -296.52% |
| 2022-03-31 | $-20.24M | $6.15M | $1.38M | $2.97M | $22.03M | -329.31% |
| 2021-12-31 | $-20.04M | $5.45M | $1.39M | $2.54M | $21.57M | -367.68% |
| 2021-09-30 | $-20.89M | $4.89M | $1.91M | $2.81M | $21.06M | -427.41% |
| 2021-06-30 | $-21.40M | $4.48M | $1.90M | $2.97M | $21.00M | -477.38% |
| 2021-03-31 | $-22.12M | $3.97M | $1.80M | $3.18M | $21.00M | -557.73% |
| 2020-12-31 | $-24.75M | $3.50M | $1.74M | $4.20M | $21.84M | -707.94% |
| 2020-09-30 | $-27.03M | $3.24M | $1.31M | $4.81M | $23.69M | -833.63% |
| 2020-06-30 | $-33.43M | $2.84M | $1.32M | $6.49M | $26.87M | -1175.34% |
| 2020-03-31 | $-39.89M | $2.71M | $1.30M | $7.97M | $30.98M | -1469.57% |
| 2019-12-31 | $-46.09M | $2.39M | $1.16M | $9.90M | $35.42M | -1928.17% |
| 2019-09-30 | $-53.16M | $2.08M | $958.41K | $11.74M | $40.55M | -2552.41% |
| 2019-06-30 | $-55.82M | $1.55M | $701.54K | $11.76M | $44.06M | -3599.49% |
| 2019-03-31 | $-59.67M | $1.32M | $687.59K | $13.62M | $46.68M | -4515.45% |
| 2018-12-31 | $-54.55M | $992.95K | $578.74K | $12.47M | $42.50M | -5494.07% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $-30.00M | $775.46K | (m) | (m) | (m) | -3869.02% |
| 2017-12-31 | $-25.64M | $811.46K | $518.53K | $7.83M | $18.11M | -3160.31% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |